Merry Christmas

It’s time to wrap up my final consulting tasks, gather my little ones (and not-so-little-ones!) around the fire, break out the cookies and the presents, and enjoy the holiday. Thanks to all my clients, partners, friends, readers and others who have made 2007 such an enjoyable and productive year. Have a wonderful Christmas season! (Image [...]

Read Full Post »

After Hours 12_17

A high-end narrated 3-D animation of the “inner life of a cell.” Very cool. Where can you find some good (low-cost or no-cost) images? Here’s a helpful list. If you use Facebook at all, you’ll get a kick out of this spoof glimpse into Facebook 30 years in the future. And finally, an inspirational year-end [...]

Read Full Post »

Pharma News 12_17

Some interesting oncology results: Millennium‘s Velcade used in combo therapy for multiple myeloma shows impressive results. Cephalon‘s Treanda shows impressive remission numbers for CLL, and effectiveness in non-Hodgins lymphoma (NHL). Celgene‘s Revlimid continues to produce good results at a low-dose regimen. Novartis‘ Gleevec: effective at halting leukemia progression up to 6 years. Eisai decides to [...]

Read Full Post »

Licensing Pharma Sales Reps?

In Washington, D.C. there is a movement to do just that. What’s disturbing is the broad-brush, assumption of guilt revealed in words like these: The District could become the first jurisdiction in the country to license pharmaceutical sales representatives, a move a council member says would help protect doctors and patients from disreputable agents who [...]

Read Full Post »

After Hours 12_7

It’s official – Style has now replaced Substance (30 second audio). Would you pay $120.00 for a beer? Something as simple as a water droplet can make a great photo. Examples here and here. Do you have teenagers (I have 3…so far). Then this will make sense to you! It is now posted in our [...]

Read Full Post »

Pharma News 12_7

The connection between high cholesterol and risk of stroke is questioned. Is Avandia contributing to bone breakage? And more bad news for the GSK diabetes treatment…two healthcare providers drop the medication from their formularies. For switcheroos, it appears that most doctors are leaning toward Januvia or Byetta. Long-ish article from Business Week on Genentech‘s current [...]

Read Full Post »

Pharma Web Branding, Part 6 – Sanofi-Aventis

This is the sixth in an occasionaly series on home page design for pharma companies. Today, we take a look at Sanofi-Aventis. On my marketing blog, I have previously remarked on S-A’s logo/tagline (“Because Health Matters”) – now for the implementation of their web presence. In a word…blecchh. Everything is whacked out, proportionally speaking, on [...]

Read Full Post »

Behemoth Pharmaceutical Hires Notre Dame Coach as CEO

In a surprise move announced today, Behemoth Pharmaceutical has hired Charlie Weis, former Notre Dame football coach, to be CEO. “We needed some fresh leadership around here, and Charlie Weis, with his background in sports metaphors, seemed like the ideal choice,” stated Frank Gipper, current Chairman of the Board. “When he came and spoke to [...]

Read Full Post »

Some Learning and Training links

From Chief Learning Officer website: The evolution of the LMS – a brief history of how LMS platforms have evolved. Companion reading to my recent rant about LMS! Using business simulations – this article talks about one particular Sim, but I have solid partners who can help you create pharma-specific sims for both field training, [...]

Read Full Post »

“We need a Learning Management System!” Really?

Do you? I’ve recently been reading over proposals for learning management platforms (2 separate initiatives), and a lot of them bother me. There are multiple reasons why (more below), but maybe the main point is this: a LMS is now a utility, a means to an end. What you really need is a sales force [...]

Read Full Post »